Literature DB >> 24646086

Macrophages: important players in primary Sjögren's syndrome?

Delu Zhou1, Nancy A McNamara.   

Abstract

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disorder characterized by immune-mediated destruction of the salivary and lacrimal glands with unknown etiology. Due to recent research utilizing human subjects as well as laboratory animal models, our understanding of the pathophysiological and immunological mechanisms of pSS has made great strides. As a consequence, targeted, immune-based therapies are gaining increased attention as the ideal way to conquer autoimmune diseases like pSS. Currently, however, there is no effective treatment to target specific immunological events or effector immune cells in the pathogenesis of pSS (discussed in other reviews of the current issue). Here, we summarize our current understanding and knowledge of the roles of monocytes/macrophages in the pathogenesis of pSS. Human studies, especially utilizing salivary gland biopsies, demonstrate the infiltration of macrophages and its correlation with disease severity. Moreover, animal model studies have shown the functional involvement of macrophages in promoting the ocular component of pSS.

Entities:  

Mesh:

Year:  2014        PMID: 24646086     DOI: 10.1586/1744666X.2014.900441

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   5.124


  14 in total

Review 1.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 2.  Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.

Authors:  Hawra Aljanobi; Amarpreet Sabharwal; Bralavan Krishnakumar; Jill M Kramer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-01-24

3. 

Authors:  渊 任; 戈丹 崔; 永翔 高
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

Review 4.  Research progress on inflammatory mechanism of primary Sjögren syndrome.

Authors:  Yuan Ren; Gedan Cui; Yongxiang Gao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

5.  MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs via miR-100-5p.

Authors:  Na Li; Zhiqi Gao; Lu Zhao; Bei Du; Binyun Ma; Hong Nian; Ruihua Wei
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

6.  Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease.

Authors:  Yuan Gao; Kyungji Min; Yibing Zhang; John Su; Matthew Greenwood; Karsten Gronert
Journal:  J Immunol       Date:  2015-08-31       Impact factor: 5.422

Review 7.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

8.  The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.

Authors:  Linbo Li; Jing He; Lei Zhu; Yuqin Yang; Yuebo Jin; Rulin Jia; Xu Liu; Yanying Liu; Xiaolin Sun; Zhanguo Li
Journal:  J Immunol Res       Date:  2015-09-08       Impact factor: 4.818

9.  Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.

Authors:  Ayumi Nishikawa; Katsuya Suzuki; Yoshiaki Kassai; Yuumi Gotou; Maiko Takiguchi; Takahiro Miyazaki; Keiko Yoshimoto; Hidekata Yasuoka; Kunihiro Yamaoka; Rimpei Morita; Akihiko Yoshimura; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2016-05-14       Impact factor: 5.156

Review 10.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.